Robarts Research Institute
London, ON, Canada
Marlys L. Koschinsky PhD, FAHA, FNLA, FACC, FCAHS, OOnt
Marlys L. Koschinsky, PhD, is a Professor in the Department of Physiology and Pharmacology and a Robarts Research Institute Scientist at Schulich School of Medicine & Dentistry, University of Western Ontario. She holds a PhD in Biochemistry from the University of British Columbia in Molecular Genetics. Dr. Koschinsky completed her post-doctoral work as a Canadian University-Industry Fellow at Genentech Inc. (San Francisco, CA; 1988-1991) where she first began her work on lipoprotein(a) (Lp(a).
Over her research career, Dr. Koschinsky has focused on studying the contribution of elevated Lp(a) to the development of cardiovascular disease. She is an internationally recognized opinion leader in Lp(a) research and has unraveled many mysteries surrounding the metabolism and pathophysiology of this enigmatic lipoprotein. Her research program has received both research and/or salary awards from provincial and national sources, charitable foundations, and the private sector; through numerous national and international research collaborations with biomedical researchers, clinicians, and pharmaceutical companies, she has helped translate knowledge from basic biochemistry and cell biology to preclinical, clinical, and R&D applications. Dr. Koschinsky has published over 180 peer-reviewed articles as well as numerous reviews, book chapters, opinion pieces, and consensus statements on Lp(a) and has delivered over 120 guest lectures in 8 countries. She has received numerous awards and accolades including the McDonald Scholarship and Career Investigator Award (Heart and Stroke Foundation of Ontario), is a Fellow of the Royal Society of Canada, American Heart Association, National Lipid Association, and American College of Cardiology, and has been appointed to the Order of Ontario.
Disclosure information not submitted.
SY35-01 - What’s on the Horizon for Reducing Lp(a)?
Sunday, June 14, 2026
4:30 PM - 5:00 PM CT